Truncating Titin (TTN) Variants in Chemotherapy-Induced Cardiomyopathy

被引：58
|
作者：
Linschoten, M. [1 ]
Teske, A. I. [1 ]
Baas, A. F. [2 ]
Vink, A. [3 ]
Dooijes, D. [2 ]
Baars, H. F. [4 ]
Asselbergs, F. W. [1 ,5 ,6 ,7 ,8 ]
机构：
[1] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Cardiol, Room E03-511,POB 85500, NL-3508 GA Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Genet, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands
[4] Elisabeth TweeSteden Ziekenhuis, Dept Cardiol, Tilburg, Netherlands
[5] Netherlands Heart Inst, Durrer Ctr Cardiovasc Res, Utrecht, Netherlands
[6] UCL, Fac Populat Hlth Sci, Inst Cardiovasc Sci, London, England
[7] UCL, Farr Inst Hlth Informat Res, London, England
[8] UCL, Inst Hlth Informat, London, England
来源：
JOURNAL OF CARDIAC FAILURE | 2017年 / 23卷 / 06期
关键词：
Cardiotoxicity; chemotherapy; heart failure; genetics; CARDIOTOXICITY;
D O I：
10.1016/j.cardfail.2017.03.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Chemotherapy-induced cardiomyopathy (CCMP) is a complication of chemotherapy treatment occurring in 9% of patients treated with the use of anthracyclines. Currently, risk stratification is based on clinical risk factors that do not adequately account for variable individual susceptibility. This suggests the presence of other determinants. In this case series, we describe 2 women with breast cancer who developed severe heart failure within months after chemotherapy. Genetic screening revealed truncating frameshift mutations in TTN, encoding the myofilament titin, in both women. To our knowledge, this is the 1st report of an association between truncating ITN variants and CCMP. Because truncations in TTN are the most common cause of familial and sporadic dilated cardiomyopathy, further research is needed to establish their prevalence in patients presenting with CCMP.
引用
收藏
页码：476 / 479
页数：4
相关论文
共 50 条
  • [1] Investigation of titin expression in explanted hearts with familial dilated cardiomyopathy and TTN truncating variants
    Smoktunowicz, N.
    Vikhorev, P.
    Montgiraud, C.
    Copeland, O.
    Munster, A.
    Dos Remedios, C.
    Messer, A.
    Knoll, R.
    Marston, S.
    CARDIOVASCULAR RESEARCH, 2016, 111 : S7 - S7
  • [2] Contribution of Noncanonical Splice Variants to TTN Truncating Variant Cardiomyopathy
    Patel, Parth N.
    Ito, Kaoru
    Willcox, Jon A. L.
    Haghighi, Alireza
    Jang, Min Young
    Gorham, Joshua M.
    DePalma, Steven R.
    Lam, Lien
    McDonough, Barbara
    Johnson, Renee
    Lakdawala, Neal K.
    Roberts, Amy
    Barton, Paul J. R.
    Cook, Stuart A.
    Fatkin, Diane
    Seidman, Christine E.
    Seidman, J. G.
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2021, 14 (05): : E003389
  • [3] Non-segregation of truncating TTN variants in families with dilated cardiomyopathy (DCM)
    Fleming, A. G.
    Brett, L.
    Wilkinson, S.
    John, S.
    Briggs, L.
    Edwards, M.
    Morris-Rosendahl, D. J.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 268 - 268
  • [4] Genetic epidemiology of titin-truncating variants in the etiology of dilated cardiomyopathy
    Tabish A.M.
    Azzimato V.
    Alexiadis A.
    Buyandelger B.
    Knöll R.
    Biophysical Reviews, 2017, 9 (3) : 207 - 223
  • [5] Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the TTN Gene
    Akhtar, Mohammed Majid
    Lorenzini, Massimiliano
    Cicerchia, Marcos
    Ochoa, Juan Pablo
    Hey, Thomas Morris
    Sabater Molina, Maria
    Restrepo-Cordoba, Maria Alejandra
    Dal Ferro, Matteo
    Stolfo, Davide
    Johnson, Renee
    Larranaga-Moreira, Jose M.
    Robles-Mezcua, Ainhoa
    Rodriguez-Palomares, Jose F.
    Casas, Guillem
    Pena-Pena, Maria Luisa
    Lopes, Luis Rocha
    Gallego-Delgado, Maria
    Franaszczyk, Maria
    Laucey, Gemma
    Rangel-Sousa, Diego
    Basurte, Mayte
    Palomino-Doza, Julian
    Villacorta, Eduardo
    Bilinska, Zofia
    Limeres Freire, Javier
    Garcia Pinilla, Jose M.
    Barriales-Villa, Roberto
    Fatkin, Diane
    Sinagra, Gianfranco
    Garcia-Pavia, Pablo
    Gimeno, Juan R.
    Mogensen, Jens
    Monserrat, Lorenzo
    Elliott, Perry M.
    CIRCULATION-HEART FAILURE, 2020, 13 (10) : E006832
  • [6] Phenotypic expression and outcomes of cardiomyopathy caused by titin truncating variants: translational insights
    Perotto, M. Maria
    Radesich, C.
    Paldino, A.
    Dal Ferro, M.
    Sinagra, G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 362 - 363
  • [7] Natural history, reversibility and arrhythmias associated with truncating titin variants in dilated cardiomyopathy
    Vissing, C. R.
    Rasmussen, T. B.
    Olesen, M. S.
    Pedersen, L. N.
    Dybro, A.
    Bundgaard, H.
    Jensen, M.
    Christensen, A. H.
    EUROPEAN HEART JOURNAL, 2019, 40 : 134 - 134
  • [8] Chemotherapy-induced cardiomyopathy
    Yusuf, Syed Wamique
    Ilias-Khan, Nasreen A.
    Durand, Jean-Bernard
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2011, 9 (02) : 231 - 243
  • [9] Titin Truncating Variants in Dilated Cardiomyopathy - Prevalence and Genotype-Phenotype Correlations
    Franaszczyk, Maria
    Chmielewski, Przemyslaw
    Truszkowska, Grazyna
    Stawinski, Piotr
    Michalak, Ewa
    Rydzanicz, Malgorzata
    Sobieszczanska-Malek, Malgorzata
    Pollak, Agnieszka
    Szczygiel, Justyna
    Kosinska, Joanna
    Parulski, Adam
    Stoklosa, Tomasz
    Tarnowska, Agnieszka
    Machnicki, Marcin M.
    Foss-Nieradko, Bogna
    Szperil, Malgorzata
    Sioma, Agnieszka
    Kusmierczyk, Mariusz
    Grzybowski, Jacek
    Zielinski, Tomasz
    Ploski, Rafal
    Bilinska, Zofia T.
    PLOS ONE, 2017, 12 (01):
  • [10] PHENOTYPIC EXPRESSION AND OUTCOMES OF CARDIOMYOPATHY CAUSED BY TITIN TRUNCATING VARIANTS: TRANSLATIONAL INSIGHTS
    Perotto, Maria
    Radesich, Cinzia
    Paldino, Alessia
    Dal Ferro, Matteo
    Sinagra, Gianfranco
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
12345